- Details
- Alicia Morgans engages with Joaquin Mateo to discuss the clinically relevant challenges and approaches to somatic mutation testing in advanced prostate cancer patients. They address the difficulties in obtaining adequate tissue for testing, the concordance between different testing mechanisms, and the balance between ideal plans and clinical feasibility. Dr. Mateo emphasizes the importance of unde...
|
- Details
- Alicia Morgans interviews Phil Kantoff to discuss the Prostate Cancer Foundation’s (PCF) evolution, significant achievements, and future directions. Dr. Kantoff recounts the early challenges of prostate cancer research, including the lack of funding and interest from the pharmaceutical industry. PCF's strategic initiatives, such as small grants and the Young Investigator Award, attracted a critica...
|
- Details
- Charles Ryan and Howard Soule discuss the progress of the 2022 Prostate Cancer Foundation (PCF) TACTICAL Team Science Award campaign. The TACTICAL campaign, ( T herapy AC celeration T o I ntercept CA ncer L ethality) seeks qualified teams of academic scientists that will specifically address the development of 21st Century therapies for lethal forms of prostate cancer. These awards will be funded...
|
- Details
- Howard Soule joins Charles Ryan as they discuss a new Prostate Cancer Foundation (PCF) TACTICAL Team Science Award as part of a broader novel T herapy AC celeration T o I ntercept CA ncer L ethality (TACTICAL) campaign. These larger team science awards will consist of $3MM or more team science awards seeking new therapies for treatment-resistant and intercepting issues of treatment resistance. One...
|
- Details
- Alicia Morgans and David Quinn discuss the promotion of women through the ranks of medical oncology ensuring they have opportunities within the prostate cancer research and clinical arena. Biographies: David Quinn, MBBS, Ph.D., FR, Associate Professor of Medicine, Section Head, GU Oncology, Division of Cancer Medicine and Blood Diseases, Keck School of Medicine USC Alicia Morgans, MD, MPH , Genito...
|
- Details
- Alicia Morgans and Shahneen Sandhu discuss the advancements in targeted radioligand therapy for prostate cancer. Dr. Sandhu emphasizes the pioneering work done in Germany and her team's contributions in running the first prospective study on lutetium PSMA. Their research reveals significant PSA response rates and quality of life improvements in patients. The conversation also explores the importan...
|
- Details
- Alicia Morgans and Andrea Miyahira discuss how the Prostate Cancer Foundation (PCF) supports the development and research endeavors of women investigating prostate cancer and science. They discuss the objectives of the Women in Science Forum at the Prostate Cancer Foundation Annual Scientific Retreat. Biographies: Andrea K. Miyahira, Ph.D., Director of Research, Prostate Cancer Foundation Alicia M...
|
- Details
- Alicia Morgans speaks with Jeremie Calais about the evolving landscape of theranostic and imaging modalities in prostate cancer. The discussion primarily focuses on the role of PSMA PET imaging in patient selection for PSMA-directed therapies like lutetium PSMA. Dr. Calais elaborates on the criteria used in the VISION trial and the complexities surrounding the necessity of targeted imaging for tar...
|
